Communications Department
202.626.8825
mediarelations@nrlc.org
By Dave Andrusko There’s so much going on that it’s easy for 99% of the public to think that Ian Wilmut, the cloner of “Dolly” the sheep, is still invested in cloning. He’s not, as a story in a California newspaper reminded us yet again yesterday. Moreover he is...
By Wesley J. Smith At least he read the piece, but John Farrell wrote right past the point in attempting to rebut my recent Weekly Standard column about the media’s biased coverage of Geron’s abandonment of embryonic stem cell research. From “A Conservative Protest...
By Wesley J. Smith Remember Ron Reagan’s nonsense speech about embryonic stem cell research (actually human cloning research) at the 2004 Democratic Convention? Media swooned at the garbage and the hype (e.g., Parkinson’s cures around 2014, “self repair kits” stored...
By Dave Andrusko We’ve run two keenly insightful posts by bioethicist Wesley Smith, including one today, on the fiasco that is the Geron corporation’s decision last week to “pull the plug” (as the Los Angeles Times put it) on its research into the use of embryonic...
Why you’re not hearing much about embryonic stem cells these days. By Wesley J. Smith For years, the media touted the promise of embryonic stem cells. Year after year, Geron Corporation announced that its embryonic stem cell treatment for acute spinal cord injury...
Wesley J. Smith This is huge. Geron, which has spent many years touting its embryonic stem cell program as the future of regenerative medicine, is abandoning the field. From the Washington Post story: “The company doing the first government-approved test of embryonic...
By Peter Saunders The BBC today is running a new stem cell story with the grandiose title ‘UK medics lead Europe's first embryonic stem cell trial’ as follows: Doctors at Moorfields Eye hospital in London have been given the go-ahead to carry out Europe's first...
Editor’s note. The following trio of items by Dr. David Prentice appeared on his fine blog at frcblog.com An Israeli company is conducting a clinical trial using a patient’s own adult stem cells to treat ALS (Lou Gehrig’s disease.) The method was developed by...
By Dave Andrusko A study out of the University of Wisconsin released late Sunday night concludes that embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) are 99% identical. While caution should always be exercised, the potential impact is enormous....
By Dave Andrusko Editor’s note. My family is on vacation. While we are gone I’ll be running articles from the past 12 months that you've indicated you particularly enjoyed. Dave "The new direct-conversion approach avoids embryonic stem cells and the whole notion of...